Dainippon Sumitomo to buy out U.S. drugmaker Sepracor

OSAKA, Japan - Photo taken Sept. 3 shows the headquarters of Dainippon Sumitomo Pharma Co. in Osaka. The company said the same day it has agreed to buy out Sepracor Inc., a Massachusetts-based pharmaceutical maker, for around $2.6 billion in an attempt to tap into the U.S. market.

Sample
PDF Preview

Product Code
ILEA001136751

Registered date
2009/9/03 00:00:00

Credit
Kyodo / Kyodo News Images

Media source
2009 Kyodo News

Media size
1303 × 1865 pixel

Resolution
240 dpi

Deployment size
725.23(KB)*

Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos

COVID-19 vaccine developed by Pfizer

Photo taken Feb. 17, 2021, shows a vial of COVID-19 vaccine developed by U.S. drugmaker Pfizer Inc., at a hospital in Ichihara, Chiba Prefecture. Japan began administering COVID-19 vaccinations the same day, with health workers being first to get them.

Takeda to sell nonprescription drug unit to Blackstone

Photo taken Aug. 24, 2020, in Tokyo shows Alinamin vitamin pills sold by Takeda Consumer Healthcare Co. Takeda Pharmaceutical Co. said the same day it will sell the over-the-counter medicine unit for around 242 billion yen ($2.3 billion) to U.S. investment fund Blackstone Group Inc.

Ex-Nintendo President Yamauchi dies

OSAKA, Japan - Photo shows former Nintendo Co. President Hiroshi Yamauchi. Yamauchi, known for his role in enhancing the company's global presence as a game console maker, died of pneumonia at a Kyoto hospital on Sept. 19, 2013, the company said. He was 85.

MRI headquarters in Las Vegas

LAS VEGAS, United States - Photo taken April 26, 2013, shows the headquarters in Las Vegas of asset management firm MRI International Inc. Japan's Securities and Exchange Surveillance Commission raided the Tokyo office of MRI that day as the company is suspected of mishandling funds invested by thousands of Japanese clients.

MRI International

TOKYO, Japan - Photo shows the building housing MRI International Inc.'s Japan office in Tokyo on April 26, 2013. The U.S. asset management firm is suspected of mishandling funds invested by thousands of Japanese clients, resulting in losses totaling more than 130 billion yen, sources familiar with the matter said April 26. The Securities and Exchange Surveillance Commission raided the Tokyo office of the Nevada-based company and other related locations that afternoon.

Big cruise ship arrives in Kobe

OSAKA, Japan - Photo taken from a Kyodo News helicopter shows the MS Voyager of the Seas, one of the world's largest cruise ships, shortly after its arrival at Kobe port on Aug. 6, 2012. The 311-meter, 137,276-ton ship, operated by a U.S. company, was carrying 3,600 foreign passengers, with 2,700 of them Chinese tourists.

Big cruise ship arrives in Kobe

Dainippon Sumitomo to buy U.S. drugmaker Sepracor for $2.6 bil.

TOKYO, Japan - Dainippon Sumitomo Pharma Co. President Masayo Tada speaks about the company's plan to buy U.S. pharmaceutical maker Sepracor Inc. for about $2.6 billion (around 240 billion yen) at a news conference in Tokyo on Sept. 3. Sepracor will become a wholly owned unit of Dainippon Sumitomo Pharma America Holdings Inc., a U.S. subsidiary of the Japanese drugmaker.

Drugmaker Kowa, Israel's Teva plan joint generic drug firm

TOKYO, Japan - Shlomo Yanai (L), president and chief executive officer of Israel's Teva Pharmaceutical Industries Ltd., and Yoshihiro Miwa, president of Japanese drugmaker Kowa Co., shake hands during a press conference in Tokyo on Sept. 24 at which they announced the two companies will set up a joint generic drug company in Tokyo next year.